首站-论文投稿智能助手
典型文献
Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents
文献摘要:
Parthenolide(PTL)is a sesquiterpene lactone derived from medicinal plant feverfew(Tanacetum parthenium).Recent studies have demonstrated that it has multiple pharmacological activities,especially in the treatment of various hematological and sol-id cancers.The superior anticancer activity of PTL suggests that it has the potential to be a first-line drug.However,due to the limited physical and chemical properties,as well as bioavailability,structural modification strategies are strongly recommended to improve the anticancer activity.This review describes representative PTL derivatives obtained by different modification strategies,which are repor-ted to exert antiproliferative activities superior to the parent compound PTL.Furthermore,we also summarize their basic mechanisms on cancer-related signaling pathways,so as to explain the potential and characteristics of PTL and its derivatives in cancer therapy.
文献关键词:
作者姓名:
LIU Xingchen;WANG Xiaobing
作者机构:
Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines,School of Tradi-tional Chinese Pharmacy,China Pharmaceutical University,Nanjing 210009,China
文献出处:
引用格式:
[1]LIU Xingchen;WANG Xiaobing-.Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents)[J].中国天然药物,2022(11):814-829
A类:
feverfew,Tanacetum,parthenium,repor
B类:
Recent,advances,structural,modification,parthenolide,its,derivatives,anticancer,agents,Parthenolide,PTL,sesquiterpene,lactone,derived,from,medicinal,plant,studies,have,demonstrated,that,has,multiple,pharmacological,activities,especially,treatment,various,hematological,sol,cancers,superior,activity,suggests,potential,first,line,drug,However,due,limited,physical,chemical,properties,well,bioavailability,strategies,strongly,recommended,improve,This,review,describes,representative,obtained,by,different,which,exert,antiproliferative,parent,compound,Furthermore,also,summarize,their,basic,mechanisms,related,signaling,pathways,explain,characteristics,therapy
AB值:
0.569774
相似文献
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
Qing Wang;Li-Juan Song;Zhi-Bin Ding;Zhi Chai;Jie-Zhong Yu;Bao-Guo Xiao;Cun-Gen Ma-Research Center of Neurobiology,The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine,Shanxi University of Chinese Medicine,Jinzhong,Shanxi Province,China;Department of Physiology,Shanxi Medical University,Taiyuan,Shanxi Province,China;Institute of Brain Science,Shanxi Key Laboratory of Inflammatory Neurodegenerative Diseases,Shanxi Datong University,Datong,Shanxi Province,China;Department of Neurology,Datong Fifth People's Hospital,Datong,Shanxi Province,China;Institute of Neurology,Huashan Hospital,Institutes of Brain Science and State Key Laboratory of Medical Neurobiology,Fudan University,Shanghai,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。